BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fischer WA 2nd, Uyeki TM, Tauxe RV. Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control 2015;43:788-93. [PMID: 26116335 DOI: 10.1016/j.ajic.2015.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Kahveci Z, Selcen Kilinc-balci F, Yorio PL. Critical investigation of glove–gown interface barrier performance in simulated surgical settings. Journal of Occupational and Environmental Hygiene 2019;16:498-506. [DOI: 10.1080/15459624.2019.1600702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Skrable K, Roshania R, Mallow M, Wolfman V, Siakor M, Levine AC. The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study. PLoS Negl Trop Dis 2017;11:e0005700. [PMID: 28723900 DOI: 10.1371/journal.pntd.0005700] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
3 Kwon JH, Burnham CD, Reske KA, Liang SY, Hink T, Wallace MA, Shupe A, Seiler S, Cass C, Fraser VJ, Dubberke ER. Assessment of Healthcare Worker Protocol Deviations and Self-Contamination During Personal Protective Equipment Donning and Doffing. Infect Control Hosp Epidemiol 2017;38:1077-83. [PMID: 28606192 DOI: 10.1017/ice.2017.121] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 14.8] [Reference Citation Analysis]
4 Billioux BJ. Neurological Complications and Sequelae of Ebola Virus Disease. Curr Infect Dis Rep 2017;19:19. [PMID: 28391498 DOI: 10.1007/s11908-017-0573-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fakhri S, Mohammadi Pour P, Piri S, Farzaei MH, Echeverría J. Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals. Front Pharmacol 2021;12:742146. [PMID: 34764869 DOI: 10.3389/fphar.2021.742146] [Reference Citation Analysis]
6 Stawicki SP, Sharpe RP, Galwankar SC, Sweeney J, Martins N, Papadimos TJ, Jeanmonod D, Firstenberg MS, Paladino L, Hansoti B, Garg M. Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak. J Glob Infect Dis 2017;9:41-4. [PMID: 28584453 DOI: 10.4103/jgid.jgid_20_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE. Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9). Am J Infect Control 2016;44:e91-e100. [PMID: 27131142 DOI: 10.1016/j.ajic.2015.11.018] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 12.2] [Reference Citation Analysis]
8 Billioux BJ, Smith B, Nath A. Neurological Complications of Ebola Virus Infection. Neurotherapeutics 2016;13:461-70. [PMID: 27412684 DOI: 10.1007/s13311-016-0457-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
9 Weber DJ, Sickbert-Bennett EE, Kanamori H, Rutala WA. New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility. Am J Infect Control 2019;47S:A29-38. [PMID: 31146847 DOI: 10.1016/j.ajic.2019.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
10 Aluisio AR, Perera SM, Yam D, Garbern S, Peters JL, Abel L, Cho DK, Woldemichael D, Kennedy SB, Massaquoi M, Sahr F, Liu T, Levine AC. Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study. Trop Med Int Health 2020;25:433-41. [PMID: 31912627 DOI: 10.1111/tmi.13369] [Reference Citation Analysis]
11 Narra R, Sobel J, Piper C, Gould D, Bhadelia N, Dott M, Fiore A, Fischer WA 2nd, Frawley MJ, Griffin PM, Hamilton D, Mahon B, Pillai SK, Veltus EF, Tauxe R, Jhung M. CDC Safety Training Course for Ebola Virus Disease Healthcare Workers. Emerg Infect Dis 2017;23. [PMID: 29154748 DOI: 10.3201/eid2313.170549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]